{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:16:22Z","timestamp":1793744182197,"version":"4.6.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111468","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T08:11:07Z","timestamp":1616055067000},"page":"111468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Effect and mechanism of berberine against polycystic ovary syndrome"],"prefix":"10.1016","volume":"138","author":[{"given":"Si-wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Gober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Ting","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib1","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S2095-4964(17)60331-5","article-title":"Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft)","volume":"15","author":"Yu","year":"2017","journal-title":"J. Integr. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib3","first-page":"2683","article-title":"Effects of berberine combined with peikun pill on lipid and glucose metabolism,inflammatory factors and hormone levels in patients with insulin resistance of polycystic ovary syndrome","volume":"14","author":"SY","year":"2019","journal-title":"World Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","article-title":"Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations","volume":"126","author":"Tang","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111468_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2003-41115","article-title":"Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens","volume":"69","author":"Hwang","year":"2003","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2001-14322","article-title":"Lignans from the rhizomes of Coptis japonica differentially act as anti-inflammatory principles","volume":"67","author":"Cho","year":"2001","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biopha.2021.111468_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111468_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpba.2015.10.014","article-title":"LC-MS\/MS determination and urinary excretion study of seven alkaloids in healthy Chinese volunteers after oral administration of Shuanghua Baihe tablets","volume":"118","author":"Cheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2021.111468_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"issue":"11","key":"10.1016\/j.biopha.2021.111468_bib11","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1002\/jps.23718","article-title":"Excretion of berberine and its metabolites in oral administration in rats","volume":"102","author":"Ma","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111468_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpba.2015.07.031","article-title":"Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS\/MS","volume":"115","author":"Wang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib14","first-page":"459","article-title":"Effect of berberine on clinical, metabolic and endocrine indexes and pregnancy ourcome in women with polycystic ovary syndrome undergoing IVF treatment","volume":"25","author":"An","year":"2016","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1159\/000493412","article-title":"Berberine exerts a protective effect on gut-vascular barrier via the modulation of the wnt\/beta-catenin signaling pathway during sepsis","volume":"49","author":"He","year":"2018","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.biopha.2021.111468_bib16","doi-asserted-by":"crossref","first-page":"28089","DOI":"10.1038\/srep28089","article-title":"Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib17","first-page":"860","article-title":"The relationship between polycystic ovary syndrome and intestinal flora and the intervention of Berberine","volume":"34","author":"Wang","year":"2017","journal-title":"Tianjin J. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(03)00734-9","article-title":"The importance of insulin resistance in polycystic ovary syndrome","volume":"80","author":"Goodarzi","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biopha.2021.111468_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib20","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/humrep\/dex308","article-title":"Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes","volume":"32","author":"Tosi","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.biopha.2021.111468_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog. Horm. Res"},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib22","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7861\/clinmedicine.16-3-262","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"16","author":"Barber","year":"2016","journal-title":"Clin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2010.03.081","article-title":"Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions","volume":"94","author":"Farrell","year":"2010","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.biopha.2021.111468_bib25","first-page":"3227","article-title":"Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo","volume":"80","author":"Yki-Jarvinen","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2021.111468_bib26","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-10-0782","article-title":"Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women","volume":"164","author":"Tosi","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biopha.2021.111468_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1849162","article-title":"Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials","volume":"2016","author":"Unfer","year":"2016","journal-title":"Int. J. Endocrinol."},{"issue":"23","key":"10.1016\/j.biopha.2021.111468_bib30","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.3390\/molecules25235566","article-title":"Inositols in PCOS","volume":"25","author":"Kamenov","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib31","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2010.05.153","article-title":"Berberine inhibits PTP1B activity and mimics insulin action","volume":"397","author":"Chen","year":"2010","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2021.111468_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235404","article-title":"The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome","volume":"15","author":"Kuang","year":"2020","journal-title":"PLoS One"},{"issue":"07","key":"10.1016\/j.biopha.2021.111468_bib35","first-page":"925","article-title":"Effect of berberine on key proteins of insulin resistance pathway in PCOS rats","volume":"39","author":"Wang","year":"2019","journal-title":"Jilin J. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111468_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104544","article-title":"Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K\/AKT and MAPK pathways","volume":"110","author":"Zhang","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111468_bib37","first-page":"1","article-title":"Effect of berberine on endometrial PPARs and endocrine metabolism of PCOS rat","volume":"16","author":"Yin","year":"2019","journal-title":"Med. Innov. China"},{"issue":"8","key":"10.1016\/j.biopha.2021.111468_bib38","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib39","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/j.clnme.2013.07.002","article-title":"Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity","volume":"8","author":"Orio","year":"2013","journal-title":"e-SPEN J."},{"key":"10.1016\/j.biopha.2021.111468_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109563","article-title":"Berberine increases glucose uptake and intracellular ROS levels by promoting Sirtuin 3 ubiquitination","volume":"121","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111468_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.14","article-title":"Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093805","article-title":"Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry","volume":"9","author":"Keefe","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib43","article-title":"The mechanism of androgen actions in PCOS etiology","volume":"7","author":"Rodriguez Paris","year":"2019","journal-title":"Med Sci."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib44","first-page":"1389","article-title":"Association between levels of serum leptin and insulin resistance in patients with polycystic ovary syndrome","volume":"35","author":"Cheng","year":"2014","journal-title":"Chin. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40618-016-0569-7","article-title":"Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome","volume":"40","author":"Pappalardo","year":"2017","journal-title":"J. Endocrinol. Invest."},{"issue":"8","key":"10.1016\/j.biopha.2021.111468_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0030-1249020","article-title":"Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in Southern Italian women with polycystic ovary syndrome","volume":"42","author":"Pappalardo","year":"2010","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/JOE-19-0530","article-title":"Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model","volume":"245","author":"Aflatounian","year":"2020","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/09513590.2012.754876","article-title":"Ovulatory effects of flutamide in the polycystic ovary syndrome","volume":"29","author":"Paradisi","year":"2013","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib49","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/en.2017-03218","article-title":"Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the letrozole-induced mouse model of PCOS","volume":"159","author":"Ryan","year":"2018","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.biopha.2021.111468_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99405","article-title":"Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS","volume":"3","author":"Silva","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2014-1887","article-title":"Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization","volume":"156","author":"Caldwell","year":"2015","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib52","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.4314\/tjpr.v19i9.23","article-title":"Effect of berberine on hyperandrogenemia, ovulation dysfunction and inflammation in a mouse model of polycystic ovary syndrome","volume":"19","author":"Lu","year":"2020","journal-title":"Trop. J. Pharm. Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib53","article-title":"A Single arm pilot study of effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2006.06.038","article-title":"Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome","volume":"87","author":"Maliqueo","year":"2007","journal-title":"Fertil. Steril."},{"issue":"21","key":"10.1016\/j.biopha.2021.111468_bib55","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-11-0616","article-title":"A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome","volume":"166","author":"Wei","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111468_bib57","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-10-0985","article-title":"Berberine suppresses androgen receptor signaling in prostate cancer","volume":"10","author":"Li","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jcp.24494","article-title":"The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells","volume":"229","author":"Shen","year":"2014","journal-title":"J. Cell Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib59","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M506850200","article-title":"Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485\/491","volume":"281","author":"Horman","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib60","first-page":"4230","article-title":"Influence of berberine on hyperandrogenism of rats with polycystic ovarian syndrome and StAR protein expression","volume":"32","author":"Zhang","year":"2017","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4103\/1008-682X.169997","article-title":"Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells","volume":"18","author":"Tian","year":"2016","journal-title":"Asian J. Androl."},{"issue":"8","key":"10.1016\/j.biopha.2021.111468_bib62","first-page":"1807","article-title":"The effect of berberine on the treatment and curative effect of phlegm - damp PCOS rats","volume":"37","author":"Zhang","year":"2019","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2021.111468_bib64","first-page":"5297","article-title":"Research progress of adipose tissue in polycystic ovary syndrome","volume":"33","author":"Wang","year":"2018","journal-title":"Matern. Child Health Care China"},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib65","first-page":"188","article-title":"New research progress on the relationship between brown fat tissue and polycystic ovary syndrome","volume":"45","author":"Li","year":"2018","journal-title":"J. Int. Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111468_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mce.2012.08.006","article-title":"Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis","volume":"363","author":"Zhang","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib67","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib68","first-page":"1677","article-title":"Effect of berberine on lipid metabolism and expression of PPAR \u03b3 and insig-2 in fat of high fat rabbit model","volume":"30","author":"He","year":"2010","journal-title":"Chin. J. Gerontol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib69","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.biopha.2021.111468_bib70","first-page":"8","article-title":"Effect of berberine on D-galactose-induced polycystic ovary syndrome in mice","volume":"29","author":"Shi","year":"2019","journal-title":"China J. Mod. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib71","first-page":"47","article-title":"Effect of berberine on adiponectin expression in 3T3-L1 adipocytes","volume":"30","author":"Gu","year":"2005","journal-title":"China J. Chin. Mater. Med."},{"issue":"11","key":"10.1016\/j.biopha.2021.111468_bib72","first-page":"1983","article-title":"Effects of berberine on mRNA expression levels of PPARgamma and adipocytokines in insulin-resistant adipocytes","volume":"41","author":"Tu","year":"2016","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.biopha.2021.111468_bib73","doi-asserted-by":"crossref","unstructured":"Y. Liu, W.J. Wang, Y.S. Li, Y.Y. Ma, Y.M. He, C.Y. He, W.H. Chen, J. Ying, Effect of berberine on visfatin expression in 3T3-L1 adipocytes, Chin J Endoednol Metab 23(4) 351\u2013354. https:\/\/doi.org\/10.1016\/S1874-8651(08)60050-2.","DOI":"10.1016\/S1874-8651(08)60050-2"},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib74","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejogrb.2011.07.012","article-title":"Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome","volume":"159","author":"Xiong","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib75","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/mrd.22799","article-title":"Interleukin 1-alpha deficiency increases the expression of Follicle-stimulating hormone receptors in granulosa cells","volume":"84","author":"Uri-Belapolsky","year":"2017","journal-title":"Mol. Reprod. Dev."},{"issue":"2","key":"10.1016\/j.biopha.2021.111468_bib76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/met.2006.4.122","article-title":"Association between circulating tumor necrosis factor-alpha, Interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome","volume":"4","author":"Tarkun","year":"2006","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"16","key":"10.1016\/j.biopha.2021.111468_bib77","first-page":"2294","article-title":"Research progress of berberine on prevention and treatment of endometrial cancer related to polycystic ovary syndrome based on anti-inflammatory mechanism","volume":"30","author":"Liu","year":"2019","journal-title":"China Pharm."},{"key":"10.1016\/j.biopha.2021.111468_bib78","series-title":"Study on the anti-inflammatory effect and mechanism of Coptis In Vitro","author":"Zhang","year":"2012"},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib79","first-page":"950","article-title":"Anti-inflammatory effects of three kinds of traditional Mongolian medicine monomer and its combination on LPS-stimulated RAW264.7 macrophages","volume":"20","author":"Huang","year":"2016","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib80","first-page":"43","article-title":"Research on anti-inflammatory activity of berberine","volume":"16","author":"Li","year":"2013","journal-title":"Pract. Pharm. Clin. Remedies"},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib81","first-page":"99","article-title":"Anti-inflammatory activity of berberine in diabetes and neoplasms","volume":"19","author":"Liu","year":"2018","journal-title":"Pract. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cen.13171","article-title":"Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome","volume":"86","author":"Zhang","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib83","first-page":"633","article-title":"Recent advance on relationship betwen oxidative stres and hyperandrogenism in polycystic ovary syndrome","volume":"13","author":"Zhang","year":"2017","journal-title":"Chin. J. Obstet. Gynecol. Pediatr. Electron. Ed."},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib84","first-page":"1138","article-title":"Effects of berberine on oxidative stress and endoplasmic reticulum stress in rats with insulin resistance","volume":"24","author":"Yang","year":"2008","journal-title":"Chin. Pharmacol. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib85","first-page":"100","article-title":"Effects of berberine combined with clomiphene on endothelial function,endocrine indexes and clinical out\u2043 comes in patients with polycystic ovary syndrome and infertility","volume":"35","author":"Jin","year":"2019","journal-title":"J. Pract. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib86","first-page":"263","article-title":"The role of intestinal flora disorder in the metabolic abnormality of polycystic ovary syndrome","volume":"35","author":"Liu","year":"2019","journal-title":"J. Pract. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111468_bib87","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of gut microbiota (DOGMA) \u2013 a novel theory for the development of polycystic ovarian syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2021.111468_bib88","series-title":"The Role of Intestinal Flora in the Pathogenesis of PCOS and Insulin Resistance and Its Mechanism","author":"Yang","year":"2019"},{"key":"10.1016\/j.biopha.2021.111468_bib89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fmicb.2019.00175","article-title":"Diversity of the gut microbiota in dihydrotestosterone-induced PCOS rats and the pharmacologic effects of diane-35, probiotics, and berberine","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib90","first-page":"16","article-title":"Effect of berberine on the endometria of the PCOS rats","volume":"34","author":"Liu","year":"2017","journal-title":"Inf. Tradit. Chin. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.17219\/acem\/61987","article-title":"History of discovery of polycystic ovary syndrome","volume":"26","author":"Szydlarska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"issue":"9","key":"10.1016\/j.biopha.2021.111468_bib92","first-page":"684","article-title":"Study the therapeutic effect of berberine on PCOS patients with insulin resistance","volume":"27","author":"Ma","year":"2011","journal-title":"Chin. J. Pract. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.biopha.2021.111468_bib93","first-page":"64","article-title":"Effect of berberine in the treatment of polycystic ovary syndrome combined with insulin resistance","volume":"6","author":"Chen","year":"2016","journal-title":"China Med. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib94","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib95","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12272-014-0510-6","article-title":"Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin","volume":"38","author":"Kwon","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib96","first-page":"731","article-title":"Effectiveness evaluation analysis on berberine tablets combination with metformin treating type 2 diabetes","volume":"18","author":"Fan","year":"2018","journal-title":"Mod. Hosp."},{"issue":"7","key":"10.1016\/j.biopha.2021.111468_bib97","first-page":"1418","article-title":"Effect of berberine combined with metformin on serum inflammatory factors and islet function in type 2 diabetes mellitus","volume":"37","author":"Dong","year":"2017","journal-title":"J. Clin. Pathol. Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111468_bib98","first-page":"1836","article-title":"Effect of combination of berberine and metformin on lipid metabolism of mice with diabetes","volume":"28","author":"Sun","year":"2013","journal-title":"Acta Chin. Med."},{"key":"10.1016\/j.biopha.2021.111468_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2532935","article-title":"The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review","volume":"2018","author":"Li","year":"2018","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib100","first-page":"317","article-title":"Effect of berberine combined with Yasmin on endocrine characteristics and clinical features in adolescents with polycystic ovary syndrome","volume":"53","author":"Sang","year":"2019","journal-title":"J. Harbin Med. Univ."},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib101","first-page":"84","article-title":"Observation on the effect of berberine combined with letrozole on ovulation induction of polycystic ovary syndrome","volume":"3","author":"Li","year":"2016","journal-title":"J. Pract. Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111468_bib102","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.fertnstert.2016.05.022","article-title":"Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome","volume":"106","author":"Wu","year":"2016","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.biopha.2021.111468_bib103","first-page":"713","article-title":"Therapeutic effect of berberine combined with diformin for women with polycystic ovary syndrome and insulin resistance","volume":"35","author":"Wang","year":"2011","journal-title":"J. Zhejiang Univ. Tradit. Chin. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib104","first-page":"77","article-title":"Clinical analysis of met- formincombined with berberine in thetreatment of obese polycystic ovary syndrome","volume":"30","author":"Wang","year":"2016","journal-title":"Chin. Prim. Health Care"},{"issue":"10","key":"10.1016\/j.biopha.2021.111468_bib105","first-page":"1815","article-title":"Analysis of therapeutic effects of estradiol and progesterone combined with berberine on infertile pa- tients with non obese polycystic ovary syndrome","volume":"38","author":"Liu","year":"2017","journal-title":"Jilin Med. J."},{"issue":"6","key":"10.1016\/j.biopha.2021.111468_bib106","first-page":"837","article-title":"Effects of berberine combined with ethinylestradiol cyproterone acetate in the treatment of obese women with polycystic ovary syndrome","volume":"23","author":"Zhu","year":"2016","journal-title":"Chin. J. Prim. Med. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:20:53Z","timestamp":1760098853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221002535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":106,"alternative-id":["S0753332221002535"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111468","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect and mechanism of berberine against polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111468"}}